We are live on ! Find out more
PBM icon

Psyence Biomedical
PBM

11 hedge funds and large institutions have $1.53M invested in Psyence Biomedical in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

663% more capital invested

Capital invested by funds: $201K → $1.53M (+$1.33M)

1.77% more ownership

Funds ownership: 0% → 1.77% (+1.8%)

0% more funds holding

Funds holding: 11 → 11 (0)

0% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 6

Holders
11
Holders Change
–
Holders Change %
0%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
5
Reduced
–
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$1.82M
2
EP
Essential Planning
New Hampshire
+$350K
3
HF
HRT Financial
New York
+$123K
4
VF
Virtu Financial
New York
+$60.8K
5
UBS Group
UBS Group
Switzerland
+$59.8K

Top Sellers

Rank Fund Capital Flow
1
CF
Cantor Fitzgerald
New York
-$33.7K
2
SFFS
Stonehage Fleming Financial Services
Jersey
-$8.05K
3
Morgan Stanley
Morgan Stanley
New York
-$4.84K
4
Jane Street
Jane Street
New York
-$4.6K
5
TSS
Two Sigma Securities
New York
-$1.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
Hudson Bay Capital Management
1
Hudson Bay Capital Management
Connecticut
$744K +$1.82M +7,629 New
HCI
2
Harraden Circle Investments
New York
$385K +$872K +3,660 New
EP
3
Essential Planning
New Hampshire
$163K +$350K +1,471 New
AI
4
AdvisorShares Investments
Maryland
$56.8K +$50K +210 +64%
HF
5
HRT Financial
New York
$55K +$123K +518 +7,400%
VF
6
Virtu Financial
New York
$27K +$60.8K +255 New
UBS Group
7
UBS Group
Switzerland
$26.8K +$59.8K +251 +6,275%
Citadel Advisors
8
Citadel Advisors
Florida
$24.2K +$44.3K +186 +413%
SRL
9
Scientech Research LLC
New Jersey
$23.6K +$53.6K +225 New
CCM
10
Connective Capital Management
California
$23.5K +$53.4K +224 New
TRCT
11
Tower Research Capital (TRC)
New York
$4.21K +$7.39K +31 +344%
CF
12
Cantor Fitzgerald
New York
– -$33.7K -90 Closed
SFFS
13
Stonehage Fleming Financial Services
Jersey
– -$8.05K -22 Closed
Morgan Stanley
14
Morgan Stanley
New York
– -$4.84K -13 Closed
Jane Street
15
Jane Street
New York
– -$4.6K -12 Closed
TSS
16
Two Sigma Securities
New York
– -$1.5K -4 Closed
Geode Capital Management
17
Geode Capital Management
Massachusetts
– -$1.05K -3 Closed

PBM Hedge Fund Activity: Q4 2024 in Review

11 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Psyence Biomedical (PBM) for Q4 2024, worth a combined $1.53M — up 663% from $201K a quarter earlier.

Fund positioning in PBM was balanced in Q4 2024: 6 funds opened new positions, 6 closed out, 5 added to existing stakes and 0 trimmed.

The largest buyer was Hudson Bay Capital Management, opening a new position worth an estimated $1.82M. The largest seller was Cantor Fitzgerald, exiting entirely with an estimated $33.7K sold.

  • 11 institutional investors held Psyence Biomedical (PBM) as of Q4 2024, unchanged from Q3 2024.
  • Funds reported $1.53M of Psyence Biomedical stock for Q4 2024, up 663% quarter-over-quarter.
  • 6 funds opened new Psyence Biomedical positions in Q4 2024 and 6 closed out, a net change of 0 holders.
  • The largest Psyence Biomedical buyer in Q4 2024 was Hudson Bay Capital Management, an estimated $1.82M added.
  • The largest Psyence Biomedical seller in Q4 2024 was Cantor Fitzgerald, an estimated $33.7K sold.

Based on aggregated 13F filings for Q4 2024.